Position in BNTX
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$8,275,350
+$447,817 QoQ
Shares Held
93,107
+13.2% QoQ
Ownership
0.037%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2022
16 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in BNTX Over Time
Shares Held
Position Value (USD)
Derivatives in BNTX
reported options exposure · as of Dec 31, 2025CallValue
$342,720
CallShares
3,600
PutValue
$95,200
PutShares
1,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026Vontobel Holding Ltd. holds $92,341,956 across 47 Biotechnology names. BNTX ranks #4 (9.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
83,380 | $37,232,503 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
28,794 | $22,247,395 | |
| 3 | MRNA |
Moderna, Inc.
|
163,422 | $8,301,837 | |
| 4 | BNTX |
BioNTech SE
This page
|
93,107 | $8,275,350 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
5,476 | $1,811,842 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
17,872 | $1,327,174 | |
| 7 | MCRB |
Seres Therapeutics, Inc.
|
138,468 | $1,228,211 | |
| 8 | OCUL |
Ocular Therapeutix, Inc
|
135,605 | $1,148,574 |
All Filings in BNTX
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $8,275,350 | 93,107 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $95,200 | 1,000 | Put | Defined | 2026-02-13 | |
| 2025-12-31 | $342,720 | 3,600 | Call | Defined | 2026-02-13 | |
| 2025-12-31 | $7,827,533 | 82,222 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $7,110,106 | 72,096 | Shares | Defined | 2025-10-15 | |
| 2025-06-30 | $6,385,218 | 59,972 | Shares | Defined | 2025-07-23 | |
| 2025-06-30 | $127,764 | 1,200 | Call | Defined | 2025-07-23 | |
| 2025-03-31 | $1,992,574 | 21,882 | Shares | Defined | 2025-04-28 | |
| 2024-12-31 | $2,436,820 | 21,385 | Shares | Defined | 2025-01-30 | |
| 2024-09-30 | $2,037,854 | 17,158 | Shares | Defined | 2024-10-16 | |
| 2024-06-30 | $3,675,022 | 45,732 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $4,398,571 | 47,681 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $4,383,391 | 41,533 | Shares | Defined | 2024-06-04 | |
| 2023-09-30 | $6,807,164 | 62,658 | Shares | Defined | 2024-06-04 | |
| 2023-06-30 | $10,244,067 | 94,914 | Shares | Defined | 2024-06-04 | |
| 2023-03-31 | $14,858,210 | 119,276 | Shares | Defined | 2024-06-04 | |
| 2022-12-31 | $1,314,424 | 8,750 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $785,405 | 5,823 | Shares | Defined | 2022-11-04 | |
| 2022-06-30 | $903,098 | 6,057 | Shares | Defined | 2022-07-27 | |
| No filing history on record for this holder in this stock. | ||||||